Volpara (ASX:VHT) share price soars on first positive cashflow

The Volpara Health Technologies Ltd (ASX:VHT) share price has jumped higher after the ASX healthcare tech share revealed positive cashflow. 

You’re reading a free article on Rask. Join 4,000+ Australians who get our expert advice, tools, exclusive research and investment recommendations. Get your 30-day trial for $1! Learn more

The Volpara Health Technologies Ltd (ASX: VHT) share price has jumped 9% higher after the ASX healthcare tech share revealed positive cashflow.

Volpara provides software that enables medical professionals to screen for breast cancer and evaluate the risk for each patient.

Strong quarter

In the third quarter of its 2023 financial year, Volpara reported that its quarterly cash receipts jumped 60%, or 42% in constant currency, to NZ$11.2 million.

That means that in the financial year to date, cash receipts were NZ$28.6 million, up 39% year over year.

This strong quarter enabled the company to achieve the first positive net cash flow quarter on record.  It achieved cashflow of NZ$1.3 million, an improvement of 134% from the outflow of NZ$3.8 million in the third quarter of FY22.

I think this is great news for the Volpara share price and heavily implies it won’t need to raise any more capital to fund the ongoing operations of the business.

The company explained that this happened because of three things.

First, a material uplift in cash receipts due to improved debtor days. In other words, the company is being paid quicker.

Second, reduced costs due to the redundancies made in the second quarter of FY23, with overall cost reductions being in line with Volpara’s revised strategy of cutting costs.

Finally, it noted government grants and the research and development totalling NZ$0.9 million. But, even without this, it would still have generated positive cashflow.

In terms of its annual recurring revenue (ARR) statistics, Volpara revealed that its contracted ARR has reached US$25.6 million, up around US$1.5 million from the second quarter of FY23. That was the joint largest increase on record.

Management comments

buy norvasc online buy norvasc online no prescription

The Volpara CEO Teri Thomas said:

We are happy to show successful execution of our strategy focused on profitable growth. As planned, our top line continues to increase while our cost base has declined. We continue to emphasise sales and positive engagements with our customers alongside settling into our streamlined operators.

Final thoughts on the Volpara share price

I think Volpara is very promising and is achieving strong growth. It has good unit economics, it just needs to keep growing to become very profitable.

I’m not sure how large it can become, but with the Volpara share price under $1 (when it was previously above $1.50), I think it has plenty of potential to deliver good returns.

CSL, Xero, ANZ... the ASX is beaten up

Right now, only brave investors are buying. Is ASX Reporting Season your KEY opportunity to act? Buy, or sell.

This coming Monday night, our two most experienced professional investors, Owen Rask and Leigh Gant, are hosting an exclusive and rare webinar on the what to watch this ASX reporting season. LIVE and free

With over 35 years of combined investing experience, join our Chief Investment Officer and Head of Content for our free Q&A.

We’ll be diving into results from CSL, Pro Medicus (ASX: PME), ANZ Bank and more. It’s absolutely free to join us. Take advantage of this volatility with our free playbook. Simply click here to view the topics.

At the time of publishing, Jaz does not have a financial or commercial interest in any of the companies mentioned.

A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

How can Rask help you?

About Rask

Learn more about us, our your community and our mission.

Rask investing philosophy

Nearly 15 years later.
It's still a work in progress.

Online investment community

You won't find our investment community on Facebook or Reddit because it's secure, free and available now.

Join 250,000+ podcast listeners

250,000 investors tune into the Rask podcasts every month. Find out why.

Find a financial planner

Australia's financial experts. At your doorstep.

Free finance courses

35,000 students have enrolled in free Rask courses. We're on a mission to 100,000.

Subscribe to Rask's free investor newsletter

53,000 Australian investors subscribe to our Sunday newsletter... and love it! It's free.

$50 million invested

We manage almost $50 million on behalf of Aussies. Discover how you can invest with us.

Better investing starts here.

Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best  insights.

Subscribe to Rask's free investor newsletter

Kick off your week with our pick of podcasts, courses and investing resources to keep your finger on the Rask pulse!

Here you go: A $50,000 per year passive income special report

Join more 50,000 Australian investors who read our weekly investing newsletter and we’ll send you our passive income investing report right now.

Simply enter your email address and we’ll send it to you. No tricks. Unsubscribe anytime.

Unsubscribe anytime. Read our TermsFinancial Services GuidePrivacy Policy. We’ll never sell your email address. Our company is Australian owned.